Animal vaccination growing industry in China

23-08-2011 | | |
Animal vaccination growing industry in China

China’s animal vaccine industry has been growing fast. The market maintained an average annual growth rate of 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY, according to a new report published by Research and Markets.

With the increase of state investment in animal epidemic funds, the expansion of compulsory immunization against animal epidemics and immunization, and the strengthening of China livestock breeding industry standardization, China’s animal vaccine industry is expected to continue to maintain a relatively high growth momentum in future, the report “China Animal Vaccine Industry Report, 2010-2011” states. 

Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few enterprises. CAHIC, Yebio QD, Guangdong Dahuanong Animal Health Products, Tecon and Chengdu Tech-Bank are representatives of the Chinese animal vaccine industry, accounting for a market share of 37.4%. Sales of these companies mainly come from the government procurement of compulsory vaccines, wherein, the revenue from government compulsory vaccines accounted for 88% of the total animal vaccine revenue of CAHIC in 2010.

According to China’s compulsory immunization plan against animal epidemics in the past three years, China not only expands the application scope of the existing animal immunization products, but also attaches great importance to the upgrading of animal vaccine products at the same time.

In recent years, the scope of China’s animal compulsory vaccinations scheme is being gradually expanded. Constrained by economic conditions, the compulsory immunization against animal epidemics currently only contains five kinds of Epidemics of Class I, while there are about 17 kinds of epidemics of Class I in China and other epidemics lead to greater risk as well. With the increasing recognition of animal epidemic prevention and control from breeding enterprises and individuals, the future demand for conventional self-pay vaccinations will be further enhanced. As China’s livestock breeding relies mainly on raising pig and poultry, Newcastle disease vaccines and porcine circovirus vaccines will be two conventional vaccines with good market prospects.